Prenetics Global Net Worth
Prenetics Global Net Worth Breakdown | PRE |
Prenetics Global Net Worth Analysis
Prenetics Global's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Prenetics Global's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Prenetics Global's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Prenetics Global's net worth analysis. One common approach is to calculate Prenetics Global's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Prenetics Global's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Prenetics Global's net worth. This approach calculates the present value of Prenetics Global's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Prenetics Global's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Prenetics Global's net worth. This involves comparing Prenetics Global's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Prenetics Global's net worth relative to its peers.
Enterprise Value |
|
To determine if Prenetics Global is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Prenetics Global's net worth research are outlined below:
Prenetics Global is way too risky over 90 days horizon | |
Prenetics Global appears to be risky and price may revert if volatility continues | |
The company reported the last year's revenue of 30.62 M. Reported Net Loss for the year was (49.81 M) with profit before taxes, overhead, and interest of 18.96 M. | |
Prenetics Global has about 176.27 M in cash with (28.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59. | |
Prenetics Global has a frail financial position based on the latest SEC disclosures | |
Roughly 20.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from globenewswire.com: World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics IM8 Health as Global Ambassador and Shareholder |
Prenetics Global uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Prenetics Global. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Prenetics Global's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of March 2024 Upcoming Quarterly Report | View | |
3rd of June 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
12th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Prenetics Global Target Price Consensus
Prenetics target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Prenetics Global's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
One | Strong Buy |
Most Prenetics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Prenetics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Prenetics Global, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPrenetics Global Target Price Projection
Prenetics Global's current and average target prices are 8.12 and 13.00, respectively. The current price of Prenetics Global is the price at which Prenetics Global is currently trading. On the other hand, Prenetics Global's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Prenetics Global Market Quote on 22nd of July 2025
Target Price
Analyst Consensus On Prenetics Global Target Price
Know Prenetics Global's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Prenetics Global is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prenetics Global backward and forwards among themselves. Prenetics Global's institutional investor refers to the entity that pools money to purchase Prenetics Global's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Prudential Corp Plc | 2025-03-31 | 428 K | Aspex Management (hk) Ltd | 2025-03-31 | 346.1 K | Nomura Holdings Inc | 2025-03-31 | 333.5 K | Ubs Group Ag | 2025-03-31 | 27.4 K | Quinn Opportunity Partners Llc | 2025-03-31 | 12.3 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 2.1 K | Bank Of America Corp | 2025-03-31 | 111 | Sbi Securities Co Ltd | 2025-03-31 | 57.0 | Wolverine Asset Management Llc | 2025-03-31 | 1.0 | Aspire Private Capital, Llc | 2024-12-31 | 0.0 |
Follow Prenetics Global's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 105.25 M.Market Cap |
|
Project Prenetics Global's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.28) | (0.30) | |
Return On Capital Employed | (0.27) | (0.26) | |
Return On Assets | (0.22) | (0.23) | |
Return On Equity | (0.27) | (0.29) |
When accessing Prenetics Global's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Prenetics Global's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Prenetics Global's profitability and make more informed investment decisions.
Please note, the presentation of Prenetics Global's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prenetics Global's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Prenetics Global's management manipulating its earnings.
Evaluate Prenetics Global's management efficiency
Prenetics Global has Return on Asset of (0.1452) % which means that on every $100 spent on assets, it lost $0.1452. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2848) %, meaning that it generated no profit with money invested by stockholders. Prenetics Global's management efficiency ratios could be used to measure how well Prenetics Global manages its routine affairs as well as how well it operates its assets and liabilities. As of July 22, 2025, Return On Tangible Assets is expected to decline to -0.3. The current year's Return On Capital Employed is expected to grow to -0.26. At present, Prenetics Global's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 107.9 M, whereas Other Assets are projected to grow to (7.1 M).Last Reported | Projected for Next Year | ||
Book Value Per Share | 13.49 | 6.93 | |
Tangible Book Value Per Share | 9.63 | 10.12 | |
Enterprise Value Over EBITDA | (0.53) | (0.55) | |
Price Book Value Ratio | 0.43 | 0.41 | |
Enterprise Value Multiple | (0.53) | (0.55) | |
Price Fair Value | 0.43 | 0.41 | |
Enterprise Value | 27.2 M | 25.8 M |
The strategic initiatives led by Prenetics Global's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 1.2493 | Revenue | Quarterly Revenue Growth 1.699 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prenetics Global insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prenetics Global's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Prenetics Global insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Prenetics Global Corporate Filings
6K | 18th of July 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
7th of May 2025 Other Reports | ViewVerify | |
30th of April 2025 Other Reports | ViewVerify | |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Prenetics Global Earnings per Share Projection vs Actual
Prenetics Global Corporate Management
Yvonne Wong | Chief Officer | Profile | |
Yung DPHIL | Chief Officer | Profile | |
Hoi Lo | Chief Officer | Profile | |
Walt Ling | Chief Genomics | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prenetics Global. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Reinsurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prenetics Global. If investors know Prenetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prenetics Global listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.81) | Revenue Per Share | Quarterly Revenue Growth 1.699 | Return On Assets | Return On Equity |
The market value of Prenetics Global is measured differently than its book value, which is the value of Prenetics that is recorded on the company's balance sheet. Investors also form their own opinion of Prenetics Global's value that differs from its market value or its book value, called intrinsic value, which is Prenetics Global's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prenetics Global's market value can be influenced by many factors that don't directly affect Prenetics Global's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prenetics Global's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prenetics Global is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prenetics Global's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.